Aug 1st, 2022 by Vizient
Jim Lichauer, Meryl Biksacky, and Conor Hanrahan discuss the strategies Intermountain Healthcare implemented to improve their immune globulin utilization.
Meryl Biksacky, PharmD
Pharmacist, Drug Information Specialist
Drug Shortage Management CO-Lead
Intermountain Healthcare Drug Information Services
Conor Hanrahan, PharmD, MS, BCPS, CPHQ
Medication Policy, Outcomes and Stewardship Director
System PGY1 Pharmacy Residency Program Director
Intermountain Healthcare Pharmacy Services
Jim Lichauer, PharmD, BCPS, FASHP
Sr Performance Improvement Program Director, Pharmacy
[01:50] Intermountain Healthcare is a complex system.
[03:19] Challenges included the size and scale of the organization, drug shortages, as well as technology and data capture issues.
[05:30] The development of IG appropriate use guidelines was intricate and enterprise-wide.
[08:21] A medication use evaluation was conducted.
[10:08] Evaluation of adherence to weight-based dosing strategies produced shocking results.
[11:41] Surveying stakeholders revealed a lack of awareness of internal guidelines and standards.
[12:42] A formal policy to optimize IG weight-based dosing is in the process of being approved.
[13:35] Advice for those planning similar strategies includes system-wide collaboration, establishing and monitoring adherence rates, standardization, and quantification of cost savings.
[15:12] Intermountain Healthcare has exciting developments on the horizon.